An asymmetric surface coating strategy for improved corrosion resistance and vascular compatibility of magnesium alloy stents
Source abstract
Abstract
Magnesium (Mg) and its alloys are promising materials for biodegradable drug-eluting stent applications, but their rapid corrosion remains a major challenge for clinical practice. Considerable efforts have been made to develop an efficient surface coating that can provide higher Mg stent corrosion resistance, sustained drug-delivery capability, and vascular compatibility. Herein, we introduce poly(ether imide) (PEI) and poly(lactic-co-glycolic acid) (PLGA) as surface coating polymers for WE43 Mg-alloy stent. Using a sequential spray-coating method, we developed a novel asymmetric stent coating comprising an inner surface coated with a PEI single layer and outer/side surfaces coated with sirolimus-loaded PLGA/PEI double layers. PEI coating layer has excellent adhesiveness to WE43 surface and considerably improves WE43 corrosion resistance and in vitro endothelial cell compatibility. PLGA/PEI double coating layer ensures a low release rate of sirolimus and stable surface morphology during drug-release process. Only vascular smooth muscle cells are directly affected by sirolimus owing to the asymmetric geometry of PLGA/PEI double coating, which has a satisfactory anti-proliferation effect. These results indicate that the developed asymmetrically PEI- and PLGA/PEI-coated WE43 stents have significant potential for achieving enhanced re-endothelialization and suppressed in-stent restenosis in vascular stent applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Polymer Surface Interaction Studies · Layered Double Hydroxides Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Shi · 2017 · 123 · 297
2. Improvement of corrosion resistance and biocompatibility of biodegradable metallic vascular stent via plasma allylamine polymerized coating10.1016/j.matdes.2016.02.039 ↗
3. Drug-eluting coronary stents: insights from preclinical and pathology studies
4. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials10.1016/S0140-6736(19)30474-X ↗
5. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver
6. Otsuka · 2014 · 129(2)0 · 211
7. Drug-eluting stents: role of stent design, delivery vehicle, and drug selection
8. Biomechanical challenges to polymeric biodegradable stents10.1007/s10439-015-1477-2 ↗
9. Developments in metallic biodegradable stents10.1016/j.actbio.2009.10.006 ↗
10. Jang · 2019 · 223 · 119461
11. Absorbable polymer stent technologies for vascular regeneration10.1002/jctb.2282 ↗
12. Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI randomized clinical trial10.1161/CIRCULATIONAHA.119.043467 ↗
13. Second-generation drug-eluting resorbable magnesium scaffold: review of the clinical evidence10.1016/j.carrev.2019.10.012 ↗
14. Ascencio · 2018 · 133 · 261
15. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial10.1016/S0140-6736(07)60853-8 ↗
16. First biodegradable metal stent in a child with congenital heart disease: evaluation of macro and histopathology
17. Ye · 2012 · 258(8) · 3420
18. Oral magnesium therapy improves endothelial function in patients with coronary artery disease10.1161/01.CIR.102.19.2353 ↗
19. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis10.1016/j.bbadis.2004.01.002 ↗
20. Ascencio · 2014 · 87 · 489
21. Wang · 2014 · 10(12) · 5213
22. Bowen · 2014 · 10(3) · 1475
23. A surface-eroding poly(1,3-trimethylene carbonate) coating for fully biodegradable magnesium-based stent applications: toward better biofunction, biodegradation and biocompatibility10.1016/j.actbio.2013.02.041 ↗
24. Kang · 2019 · 84 · 453
25. A crack-free anti-corrosive coating strategy for magnesium implants under deformation10.1016/j.corsci.2017.12.030 ↗
26. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents10.1016/j.biomaterials.2010.02.003 ↗
27. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents10.1016/j.jconrel.2006.08.023 ↗
28. Controlled release of sirolimus from a multilayered PLGA stent matrix10.1016/j.biomaterials.2006.07.016 ↗
29. Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents10.1016/j.colsurfb.2010.10.038 ↗
30. Chen · 2019 · 148 · 134
31. Zhang · 2016 · 112 · 327
32. Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating10.1016/j.actbio.2016.04.029 ↗
33. Drug-eluting bioabsorbable magnesium stent10.1111/j.1540-8183.2004.04081.x ↗
34. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents10.1001/jama.293.17.2126 ↗
35. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial10.1016/S0140-6736(08)60415-8 ↗
36. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis10.1016/S0140-6736(07)61444-5 ↗
37. In vitro degradation and cell attachment of a PLGA coated biodegradable mg-6Zn based alloy10.1007/s10853-010-4688-9 ↗
38. Interaction between a high purity magnesium surface and PCL and PLA coatings during dynamic degradation10.1088/1748-6041/6/2/025005 ↗
39. Wang · 2017 · 122 · 32
40. Mata · 2018 · 140 · 307
41. Viability and function of primary human endothelial cells on smooth poly(ether imide) films
42. Enhanced bioactivity of titanium-coated polyetheretherketone implants created by a high-temperature 3D printing process10.1088/1758-5090/ab376b ↗
43. Design and characterization of a novel biocorrodible iron-based drug-eluting coronary scaffold10.1016/j.matdes.2015.11.045 ↗
44. Jang · 2019 · 179 · 405
45. Liu · 2015 · 31(7) · 733
46. Dynamic degradation behavior of MgZn alloy in circulating m-SBF10.1016/j.matlet.2010.06.011 ↗
47. Stent application for the treatment of cerebral aneurysms10.5469/neuroint.2011.6.2.53 ↗
48. Hydroxyapatite (HA)/poly-L-lactic acid (PLLA) dual coating on magnesium alloy under deformation for biomedical applications10.1007/s10856-015-5643-8 ↗
49. Surface characteristics of PLA and PLGA films10.1016/j.apsusc.2006.05.047 ↗
50. Coatings for biodegradable magnesium-based supports for therapy of vascular disease: a general view, materials science & engineering C10.1016/j.msec.2019.04.032 ↗
51. Recent advances in manufacturing innovative stents10.3390/pharmaceutics12040349 ↗
52. Comparison study on four biodegradable polymer coatings for controlling magnesium degradation and human endothelial cell adhesion and spreading10.1021/acsbiomaterials.7b00215 ↗
53. Enhanced performance of magnesium alloy for drug-eluting vascular scaffold application10.1016/j.apsusc.2017.11.090 ↗
54. A comparison of functional and physical properties of self-expanding intracranial stents [Neuroform3, wingspan, solitaire, Leo+, Enterprise]10.1055/s-0031-1271681 ↗
55. Biodegradable metals10.1016/j.mser.2014.01.001 ↗
56. Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial10.1016/S0140-6736(12)61765-6 ↗
57. Poly(ether imide)-silica hybrid coatings for tunable corrosion behavior and improved biocompatibility of magnesium implants10.1088/1748-6041/11/3/035003 ↗
58. Use of a poly(ether imide) coating to improve corrosion resistance and biocompatibility of magnesium (mg) implant for orthopedic applications10.1002/jbm.a.34474 ↗
59. Characteristics and cytocompatibility of biodegradable polymer film on magnesium by spin coating10.1016/j.colsurfb.2011.12.009 ↗
60. Hydroxyapatite/poly(epsilon-caprolactone) double coating on magnesium for enhanced corrosion resistance and coating flexibility10.1177/0885328212468921 ↗
61. Corrosion resistance of a composite polymeric coating applied on biodegradable AZ31 magnesium alloy10.1016/j.actbio.2013.02.036 ↗